InvestorsHub Logo
Followers 13
Posts 1812
Boards Moderated 0
Alias Born 03/29/2016

Re: n3m3sis post# 4224

Wednesday, 07/19/2017 3:15:52 PM

Wednesday, July 19, 2017 3:15:52 PM

Post# of 7747
From the current Tutes holding shares they are recent ones which means Tutes bought in at offering price or at warrant price. They would take a 4$ per share and run with huge profits no doubt about that. That falls in line with the talk that Sk was in bed with Tutes. More dots connected.

Cytrx is not the first ticker that had some misleading trial results released that caused a huge share price drop, only later to get run up in dollars again from 50 cents. There shouldn't be Tutes holding shares if Aldox was worthless like some trying to bash this.

Don't forget we have a product that completed a phase 3 with success. Phase 1 to address safety, phase 2 to show effectiveness, and a phase 3 to compare with existing treatment with positive results as well as a clear FDA approval path.

For once, I am actually hoping SK get that deal through even if it was 4$ lol.